Document Detail

Monitoring Autophagy in the Treatment of Protein Aggregate Diseases: Steps Toward Identifying Autophagic Biomarkers.
MedLine Citation:
PMID:  23408309     Owner:  NLM     Status:  Publisher    
Neurodegenerative diseases such as Huntington disease, Parkinson's disease, and Alzheimer's disease are caused by the accumulation of aggregate prone proteins. Pathogenic proteins misfold, aggregate, and escape the cell's normal degradative pathways. Protein aggregates subsequently lead to the toxic disruption of normal cellular processes leading, ultimately, to disease. Several lines of evidence suggest that reducing the burden of these toxic aggregates is therapeutic. One mechanism proposed to facilitate the degradation or clearance of these protein inclusions is macroautophagy. While autophagic treatment paradigms for neurodegeneration are still in the early stages of preclinical development, it is essential to identify and validate methods to measure the activation of autophagy in human patients. These methods will serve as important biomarkers necessary to test compound efficacy and monitor clinical improvement.
Conrad C Weihl
Related Documents :
24052039 - Differential diagnosis of glomerular disease: a systematic and inclusive approach.
21285059 - Polymyositis associated with severe interstitial lung disease: remission after three do...
24470989 - Autophagy modulation in disease therapy: where do we stand?
23642059 - Differences between parkinson's and huntington's diseases and their role for prioritiza...
21135799 - Pilonidal sinus disease: a review. part one.
24265249 - Correlation between ankle brachial index and coronary artery disease severity in elderl...
7498669 - Diagnosis of wilson's disease in an asymptomatic sibling by dna linkage analysis.
10949879 - Some memoranda on the diagnostic criteria of lung disease caused by mycobacterium avium...
17938929 - Telomerase activity in connective tissue diseases: elevated in rheumatoid arthritis, bu...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-2-14
Journal Detail:
Title:  Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics     Volume:  -     ISSN:  1878-7479     ISO Abbreviation:  Neurotherapeutics     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-2-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101290381     Medline TA:  Neurotherapeutics     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Neurology, Washington University School of Medicine, PO Box 8111, 660 South Euclid Avenue, St Louis, MO, 63110, USA,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Conformational Preferences of Modified Nucleoside N(4)-Acetylcytidine, ac(4)C Occur at "Wobble" 34th...
Next Document:  Transient neutropenia in children with febrile illness and associated infectious agents: 2 years' f...